Literature DB >> 6548587

Severe inherited "homozygous" protein C deficiency in a newborn infant.

A Estellés, I Garcia-Plaza, A Dasí, J Aznar, M Duart, G Sanz, J L Pérez-Requejo, F España, C Jimenez, G Abeledo.   

Abstract

A relapsing clinical syndrome of skin lesions and disseminated intravascular coagulation (DIC) that showed remission with the infusion of fresh frozen plasma is described in a newborn infant with homozygous deficiency of protein C antigen. This patient presented since birth a recurrent clinical picture of DIC and ecchymotic skin lesions that resembled typical ecchymosis except for the fact that they showed immediate improvement with the administration of fresh frozen plasma. Using an enzyme linked immunosorbent assay method, the determination of protein C antigen levels in the patient, without ingestion of coumarin drugs, showed very low values (less than 1%). No other deficiencies in the vitamin-K-dependent factors or in antithrombin III, antiplasmin, and plasminogen were found. Seven relatives of the infant had heterozygous deficiency in protein C antigen (values between 40-55%), without clinical history of venous thrombosis. The pedigree analysis of this family suggests an autosomal recessive pattern of inheritance for the clinical phenotype, although an autosomal dominant pattern has been postulated until now in other reported families. We conclude that our patient has a homozygous deficiency in protein C and this homozygous state may be compatible with survival beyond the neonatal period.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6548587

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  15 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Persistent Fetal Vasculature and Severe Protein C Deficiency.

Authors:  A G L Douglas; H Rafferty; P Hodgkins; A Nagra; N C Foulds; M Morgan; I K Temple
Journal:  Mol Syndromol       Date:  2010-04-23

3.  Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states.

Authors:  S Vigano D'Angelo; P C Comp; C T Esmon; A D'Angelo
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

4.  Successful treatment of homozygous protein C deficiency by hepatic transplantation.

Authors:  J F Casella; J H Lewis; F A Bontempo; B J Zitelli; H Markel; T E Starzl
Journal:  Lancet       Date:  1988-02-27       Impact factor: 79.321

5.  α2-Macroglobulin Is a Significant In Vivo Inhibitor of Activated Protein C and Low APC:α2M Levels Are Associated with Venous Thromboembolism.

Authors:  Laura Martos; Luis Andrés Ramón; Julia Oto; Álvaro Fernández-Pardo; Santiago Bonanad; Ana Rosa Cid; Andras Gruber; John H Griffin; Francisco España; Silvia Navarro; Pilar Medina
Journal:  Thromb Haemost       Date:  2018-02-15       Impact factor: 5.249

6.  Heterozygous protein C deficiency type I.

Authors:  B Kemkes-Matthes
Journal:  Blut       Date:  1989-04

7.  [Homozygous infant in a family with hereditary protein C deficiency].

Authors:  G Hintz; J Weil; S Buchmann; A Azzam; K Auberger; C Beck
Journal:  Klin Wochenschr       Date:  1987-07-15

Review 8.  Clinical relevance of protein C.

Authors:  I Pabinger
Journal:  Blut       Date:  1986-08

9.  Use of human protein C concentrates in the treatment of patients with severe congenital protein C deficiency.

Authors:  Sabine Kroiss; Manuela Albisetti
Journal:  Biologics       Date:  2010-03-24

10.  An unknown genetic defect increases venous thrombosis risk, through interaction with protein C deficiency.

Authors:  S J Hasstedt; E G Bovill; P W Callas; G L Long
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.